A Study to Evaluate Ustekinumab in Clinical Practice in Patients With Plaque Psoriasis in Asia-Pacific Countries
Phase of Trial: Phase IV
Latest Information Update: 01 May 2017
Price : $35 *
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms MARCOPOLO
- Sponsors Johnson & Johnson
- 05 Feb 2014 Status changed from active, no longer recruiting to completed.
- 05 Mar 2013 Planned end date changed from 1 Nov 2013 to 1 Oct 2013 vas reported by ClinicalTrials.gov
- 28 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.